the aid library

LIST OPTIONS

Filter

8350

Download (464)

View PDF (664)

HIV Prevalence and Associated Risk Factors: Analysis of Change Over Time in Mainland Tanzania

Mmbaga, Elia John ICF International (2013) C2

DHS Working Papers No. 85

Download (497)

View PDF (775)

Uganda: Quality Improvement Manual for TB Care Services

Ministry of Health, Republic of Uganda (2017) C2

National Tuberculosis and Leprosy Control Program

Download (453)

View PDF (635)

HIV/AIDS in Ethiopia

MEASURE DHS (2013) C2

Data from the 2011 Ethiopia Demographic and Health Survey

Download (1810)

View PDF (5284)

Clinical Management of Acute Diarrhoea

World Health Organization; UNICEF (2004) C_WHO

Available in Englisch, French, Spanish and Chinese The document provides guidelines for the management of acute diarrhoea, highlighting improved oral rehydration solutions (ORS) with reduced osmolarity and zinc supplementation. It emphasizes their effectiveness in reducing the duration and severity... more

Download (183)

View PDF (164)

Guiding principles for prioritizing malaria interventions in resource constrained country contexts to achieve maximum impact

World Health Organisation (WHO) (2024) C_WHO

Due to the heterogeneous distribution of malaria transmission and its determinants, subnational tailoring (SNT) provides an analytical framework to facilitate the targeting of each population with appropriate intervention packages for maximum impact to inform national strategic planning and prioriti... more

Download (109)

View PDF (452)

Tackling malaria in countries hardest hit by the disease: ministerial conference report, Yaoundé, Cameroon, 6 March 2024

World Health Organisation (WHO) (2024) C_WHO

The Malaria Ministerial Conference, co-hosted by WHO and the Government of Cameroon on 6 March 2024, brought together more than 400 stakeholders, including Ministers of Health and senior representatives from the African countries hardest hit by malaria, global health leaders, scientists, civil socie... more

Download (42)

View PDF (23)

Consensus Statement on c-IPTp

RBM Partnership to End Malaria (2024) C2

The Consensus Statement on c-IPTp is a publication by the RBM Partnership to End Malaria. It focuses on community-based intermittent preventive treatment in pregnancy (c-IPTp), aiming to enhance malaria prevention among pregnant women through community-level interventions. The statement offers po... more

Download (45)

View PDF (24)

Declaration by African Youth to End Malaria in Africa by 2030

RBM Partnership to End Malaria (2023) C2

The Declaration by African Youth to End Malaria in Africa by 2030 is a commitment from young people across Africa to eradicate malaria by the year 2030. In this document, they outline specific strategies and actions they pledge to undertake, emphasizing the importance of youth involvement in mala... more

Download (158)

View PDF (246)

Mpox Molecular Diagnostic Tests(RT-PCR)

Africa Center for Disease Control and Prevention (2024) CC

On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ... more

Diabetes self-management education interventions in the WHO African Region: A scoping review

Kumah, E.; Otchere, G.; Egyakawa Ankomah, S.; et al. PLoS One (2021) CC2

Diabetes mellitus (DM) is one of the commonest chronic diseases worldwide. Self-Management Education (SME) is regarded as a critical element of treatment for all people with diabetes, as well as those at risk of developing the condition. While a great variety of diabetes self-management education (D... more

External Link

How to build a Tippy Tap?

SPRINGBangladesh (2015) C2

The brochure "How to Build Your Own Tippy Tap", published by SPRING in 2015, provides step-by-step instructions for creating a simple handwashing device called a tippy tap. It highlights the importance of hand hygiene and demonstrates how to construct the device using locally available, low-cost mat... more

Download (357)

View PDF (476)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (48)

View PDF (32)

Plan of Action for Malaria Elimination 2021-2025

Pan American Health Organization (PAHO) (2022) C_WHO

The Plan of Action for Malaria Elimination 2021-2025 has been developed in consultation with countries and regional partners as a framework of reference to guide the efforts of countries and the contributions of donors and partners towards elimination of the disease in the Americas. The Plan subscri... more

External Link

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended

World Health Organization WHO (2023) C_WHO

2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The ... more

Download (226)

View PDF (218)

Strategic Framework for Enhancing Prevention and Control of mpox, 2024-2027

World Health Organization WHO (2024) C_WHO

Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani... more

Download (93)

View PDF (141)

City-level monitoring guidance for the prevention and control of noncommunicable diseases and injuries

World Health Organisation (WHO) (2024) C_WHO

The guidance document provides a set of indicators for assessing the status of development, implementation and monitoring of key policy interventions for prevention and control of NCDs and injuries. It promotes city-level evidence based decision-making processes to identify gaps and take appropriate... more

Download (952)

View PDF (1503)

Revised WHO classification and treatment of childhood pneumonia at health facilities

World Health Organization (2014)

The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o... more

Download (41)

View PDF (22)

Manual for Stratifying Malaria Risk and the Elimination of Foci

Pan American Health Organization (PAHO) (2022) C_WHO

All malaria-endemic countries in the Region of the Americas have taken on the challenge to eliminate the disease and to put in place measures to orient their health programs and strategies in that direction. This manual explains how to implement measures to achieve malaria elimination and prevent it... more

Download (1521)

View PDF (2683)

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

Download (1383)

View PDF (3126)

Tool for the assessment of injection safety

World Health Organization (2001) C_WHO

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended